Novel genes detected by transcriptional profiling from whole-blood cells in patients with early onset of acute coronary syndrome

Transcriptomic analysis by microarray technology demonstrated differential expression during a 48 h time course suggesting a potential use of some of these genes as biomarkers for very early stages of ACS, as well as for monitoring early cardiac ischemic recovery.